Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fate Therapeutics (FATE)
NASDAQ:FATE
Fate Therapeutics (FATE) Ownership - Who Owns Fate Therapeutics?
1,112 Followers
Fate Therapeutics (FATE) Ownership Overview
24.99% Insiders
22.28% Mutual Funds
15.10% Other Institutional Investors
37.63% Public Companies and
Individual Investors
The ownership structure of Fate Therapeutics (FATE) stock is a mix of institutional, retail and individual investors. Approximately 37.38% of the company’s stock is owned by Institutional Investors, 24.99% is owned by Insiders and 37.63% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 10, 2024 | xxxxxxxxxxxxx | $30712 | |
| Jan 10, 2024 | Cindy Tahl Gc & Secretary | xxxxxxxxxxxxx | $47519 |
| Jan 10, 2024 | Scott Wolchko President & Ceo,director | xxxxxxxxxxxxx | $62889 |
| Jan 10, 2024 | Bahram Valamehr Chief R&d Officer | xxxxxxxxxxxxx | $49367 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $318548 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $2129972 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $13345448 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $13887294 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,969,213 | Institution | 5.24% | 25,488,540 | |
| 5,018,802 | Institution | 4.41% | 21,430,285 | |
| 3,972,648 | Institution | 3.49% | 16,963,207 | |
| 3,262,362 | Institution | 2.87% | 13,930,286 | |
| 2,856,450 | Institution | 2.51% | 12,197,042 | |
| 2,515,964 | Institution | 2.21% | 10,743,166 | |
| 2,190,408 | Institution | 1.92% | 9,353,042 | |
| 1,892,002 | Institution | 1.66% | 8,078,849 | |
| 1,818,181 | Institution | 1.60% | 7,763,633 | |
| 1,268,133 | Institution | 1.11% | 5,414,928 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,969,213 | Institution | 5.24% | 25,488,540 | |
| 2,856,450 | Institution | 2.51% | 12,197,042 | |
| 2,515,964 | Institution | 2.21% | 10,743,166 | |
| 1,268,133 | Institution | 1.11% | 5,414,928 | |
| 1,099,314 | Institution | 0.97% | 4,694,071 | |
| 948,680 | Institution | 0.83% | 4,050,864 | |
| 944,400 | Institution | 0.83% | 4,032,588 | |
| 931,034 | Institution | 0.82% | 3,975,515 | |
| 924,315 | Institution | 0.81% | 3,946,825 | |
| 635,972 | Institution | 0.56% | 2,715,600 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,663,141 | Institution | 2.34% | 11,371,612 | |
| 2,577,403 | Institution | 2.26% | 11,108,607 | |
| 2,962,285 | Institution | 2.60% | 9,716,295 | |
| 1,304,546 | Institution | 1.15% | 4,278,911 | |
| 935,061 | Institution | 0.82% | 3,992,710 | |
| 558,228 | Institution | 0.49% | 2,405,963 | |
| 458,779 | Institution | 0.40% | 1,977,337 | |
| 392,460 | Institution | 0.34% | 1,691,503 | |
| 372,708 | Institution | 0.33% | 1,222,482 | |
| 266,155 | Institution | 0.23% | 1,147,128 |
FAQ
Who Owns Fate Therapeutics (FATE)?
According to the latest TipRanks data, approximately 15.10% of the company's stock is held by institutional investors, 24.99% is held by insiders, and 37.63% is held by retail investors.
What percentage of Fate Therapeutics (FATE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 15.10% of Fate Therapeutics (FATE) stock is held by institutional investors.
What percentage of Fate Therapeutics (FATE) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.63% of Fate Therapeutics (FATE) stock is held by retail investors.
Who owns the most shares of Fate Therapeutics (FATE)?
VANGUARD INDEX FUNDS owns the most shares of Fate Therapeutics (FATE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.